今日期刊推薦:Cardiovascular Diabetology
創刊時間:2002
出版國家:英國
ISSN:1375-2840
出版商:BioMed Central
Cardiovascular Diabetology這幾年的影響因子整體呈上漲趨勢,2021年8.949,目前即時因子為9,預計今年將漲至9.5左右,2022年中科院最新分區:1區top,是本值得關注的期刊。
期刊影響因子排名↓↓↓
20/143 心臟和心血管系統
15/146 內分泌學與代謝
按期刊引文指標 (JCI) 排名↓↓↓
15/208 心臟和心血管系統
10/180 內分泌學與代謝
JCR分區
中科院分區
發文情況
Cardiovascular Diabetology近幾年的發文量呈上漲趨勢,2021年文章數為217篇,發文量不大。國人發文占比約為13.6%,國人發文占比第一。
收稿範圍
Cardiovascular Diabetology心血管糖尿病學考慮有關糖尿病/心血管相互關係和代謝綜合徵各個方面的手稿;這包括臨床、遺傳、實驗、藥理學、流行病學和分子生物學研究。
版面費
Cardiovascular Diabetology是OA期刊。APC是£2790/$3690/€3090,折合人民幣23145元。
審稿周期
官網表明:
3 days to first decision for all manuscripts (Median)
28 days to first decision for reviewed manuscripts only (Median)
通過對近期已發表文章審稿速度的抽樣統計,文章的審稿周期都是在1-3個月左右接受,快的有24天可以接受的!慢的話有164天的。整體來說審稿周期屬於比較快的。僅供參考
以下為近期官網發表的RESEARCH ARTICLE實例:
1.從收到稿件到接受稿件用時:122天
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
2. 從收到稿件到接受稿件用時:40天
Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong
3.從收到稿件到接受稿件用時:90天
Relationship between red cell distribution width/albumin ratio and carotid plaque in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China
4. 從收到稿件到接受稿件用時:164天
Long-term increase in fasting blood glucose is associated with increased risk of sudden cardiac arrest
5. 從收到稿件到接受稿件用時:24天
Association between low-density lipoprotein cholesterol and sudden cardiac arrest in people with diabetes mellitus
6. 從收到稿件到接受稿件用時:132天
triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data
7. 從收到稿件到接受稿件用時:65天
Prediabetes as a risk factor for new-onset atrial fibrillation: the propensity-score matching cohort analyzed using the Cox regression model coupled with the random survival forest
8.從收到稿件到接受稿件用時:24天
Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes
自引率
Cardiovascular Diabetology近7年自引率比較高,但2021年的自引率12.5%。暫時不用擔心自引率的問題。
中科院《國際期刊預警名單》
2023版:不在預警名單中
2021版:不在預警名單中
2020版:不在預警名單中
推薦指數:☆☆☆☆
Cardiovascular Diabetology是醫學:心臟和心血管系統/內分泌學與代謝領域期刊。JCR1區,中科院1區top;2021年發文量217篇,國人發文占比第一,約為13.6%;2021年影響因子為8.949,預計今年會漲至9.61左右。需版面費;審稿周期大多1-3個月內;國人友好!手上有高質量(符合收稿範圍)稿件的作者們,趕緊沖沖沖!
PS:需要Sci潤色、翻譯、降重、等服務的老師可以私信小編。